BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Alivus Life Sciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543322
ISIN Demat
INE03Q201024
Book Value (Rs)
207.1603168
NSE Symbol
ALIVUS
Divident Yield %
2.07
Market Cap
(Rs In Cr.)
13,342
P/E (TTM)
30.2
EPS (TTM)
36.05
Face Value
(Rs)
2
Back
Alivus Life Sciences Ltd - Alivus Life Sciences Limited - Press Release
23-Jan-25   Hrs IST

Alivus Life Sciences Limited has informed the Exchange regarding a press release dated January 23, 2025, titled 'Press Release on the Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2024'.

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)